Skip to main content
. 2019 Aug;31(4):557–577. doi: 10.21147/j.issn.1000-9604.2019.04.01

A6.

TNMB stage system of Mycosis fungodies and Sézary syndrome

Stage Clinical manifestations
Skin
 T1 Localized patches, papules, and/or plaques, <10% body surface area
 T2 Patches, papules, and/or plaques, ≥10% body surface area
 T3 One or more lumps are formed (diameter ≥1 cm)
 T4 Fusional erythema ≥80% body surface area
Lymph nodes
 N0 No abnormal lymph nodes; no biopsy required
 N1 Abnormal lymph nodes; histopathology shows Dutch level 1 or NCI LN 0−2
 N2 Abnormal lymph nodes; histopathology shows Dutch level 2 or NCI LN 3
 N3 Abnormal lymph nodes; histopathology shows Dutch level 3−4 or NCI LN 4
 NX Abnormal lymph nodes; no histological confirmation
Viscera
 M0 No viscus involvement
 M1 Visceral involvement (required pathological diagnosis and indication of the affected organs)
 MX Visceral abnormalities; no histological diagnosis
Blood
 B0 No obvious blood involvement: atypical cells (Sézary cells) accounts for 5% of peripheral blood lymphocytes
 B1 Low-load blood involvement: atypical cells (Sézary cells) accounts for >5% of peripheral blood lymphocytes, but do not reach B2 level
 B2 High-load blood involvement: atypical cells (Sézary cells) ≥1,000/μL or CD4+/CD7− cell ratio ≥40% or CD4+/CD26− cell ratio ≥30%